AGP Executive Report
Last update: 8 hours agoDisease Preparedness: Singapore has launched a regional One Health initiative using predictive modelling to spot infectious disease threats earlier, linking human, wildlife and environmental health partners. India’s Hospital Sector: Kauvery Hospital opened an integrated obesity and metabolic-care centre in Chennai and performed South Tamil Nadu’s first deceased-donor liver transplant; Dr Lal PathLabs also reported a 27% profit rise as testing volumes grew. Drug Development: Nxera Pharma licensed its inflammatory bowel disease candidate to AbbVie for US$100 million upfront and up to US$1.37 billion in milestones. Boehringer Ingelheim and China’s SBP Group also struck a cancer-drug partnership worth US$358 million upfront and near-term payments, with further milestones possible. Outbreak Watch: Japan’s flu season began unusually early, with children and older adults making up most hospitalisations. Dengue has also prompted quarantines at construction sites in China’s Hainan province. Health Policy: A Lancet Commission report says China’s poverty-reduction programme combined healthcare with measures on nutrition, housing and safe water; it cites 1.4 trillion yuan in health-related investment from 2015 to 2020.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
